| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |